A 7-year-old child with Down syndrome and disruptive behaviors.
Cohen
William I
WI
Down Syndrome Center, Children's Hospital of Pittsburgh, Pennsylvania, USA.
Liu
Yi Hui
YH
Stein
Martin T
MT
D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use; D019958:Attention Deficit and Disruptive Behavior Disorders / Q000139:chemically induced / Q000175:diagnosis* / Q000523:psychology; D002648:Child; D015897:Comorbidity; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004314:Down Syndrome / Q000175:diagnosis* / Q000523:psychology; D006330:Heart Defects, Congenital / Q000175:diagnosis / Q000523:psychology; D006760:Hospitalization; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D008140:Lorazepam / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D010102:Oxygen Inhalation Therapy; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000523:psychology; D011687:Purines / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000009:adverse effects / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D008140:Lorazepam